(the "Company")
The Company has been notified that Nigel Rogers, Executive Chairman, today:
(i) acquired 750,000 ordinary shares of 1 penny each in the Company ("Shares") within his ISA, at a price of 2.95p per share; and
(ii) sold 416,830 Shares at a price of 2.95p per share.
Following these transactions, the beneficial holding of Nigel Rogers in the Company is 6,610,000
Shares, representing approximately 0.84% of the issued share capital of the Company.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
|
Surgical Innovations Group plc Nigel Rogers, Executive Chairman Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker) Tim Feather
Walbrook PR (Financial PR & Investor Relations) Paul McManus Lianne Cawthorne |
|
|
Tel: 0113 230 7597 |
|
|
Tel: 0113 394 6600 |
|
|
Tel: 020 7933 8780 or si@walbrookpr.com |
|
|
Mob: 07980 541893 |
|
|
Mob: 07584 391303 |
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
Name |
Nigel Rogers |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Executive Chairman, Surgical Innovations Group plc |
||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Surgical Innovations Group plc |
||||
|
b) |
LEI |
2138004GHGUH3HUZE156 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p
GB0004016704 |
||||
|
b) |
Nature of the transactions |
Purchase of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
|
2.95p |
750,000 |
|||||
|
|
||||||
|
d) |
Aggregated information - Aggregated volume - Price |
750,000 £22,125 |
||||
|
e) |
Date of the transaction |
16 October 2018 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM |
||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name |
Nigel Rogers |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
Executive Chairman, Surgical Innovations Group plc |
|||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Surgical Innovations Group plc |
|||
|
b) |
LEI |
2138004GHGUH3HUZE156 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p
GB0004016704 |
|||
|
b) |
Nature of the transactions |
Sale of Ordinary Shares |
|||
|
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
2.95p |
416,830 |
||||
|
|
|||||
|
d) |
Aggregated information - Aggregated volume - Price |
416,830 £12,296 |
|||
|
e) |
Date of the transaction |
16 October 2018 |
|||
|
f) |
Place of the transaction |
London Stock Exchange, AIM |
|||